Showing posts with label Ambuja Cements. Show all posts
Showing posts with label Ambuja Cements. Show all posts
23 February 2015
05 November 2014
Higher realisation leads margin expansion… • Ambuja :: ICICI Securities, PDF link
CLICK links to Read MORE reports on:
Ambuja Cements,
ICICI Securities
03 November 2014
Ambuja Cement - Realisations Surprise; Result Update Q3CY14 :: Edelweiss
CLICK links to Read MORE reports on:
Ambuja Cements,
Edelweiss
Ambuja Cements Ltd.|Q3CY14 Result Update-:: IndiaNivesh
CLICK links to Read MORE reports on:
Ambuja Cements
11 May 2014
J.P. Morgan - Ambuja Cements Limited
| Ambuja Cements Limited (ACEM IN) EBITDA marginally higher as operating costs improved; PAT beat due to one-offs | Underweight Price: Rs218.75 23 Apr 2014 Price Target: Rs155.00 PT End Date: 31 Mar 2015 | |
ACEM reported 1Q CY14 EBITDA of Rs5.9bn, which was 5% ahead of JPMe but well above consensus at Rs5.3bn. While revenue was largely inline with expectations, the higher-than-expected EBITDA was primarily driven by a 5% decline in operating cost sequentially. Reported PAT at Rs5.2bn was ahead of JPMe (Rs3.3bn) and Consensus (Rs3.4bn) mostly aided by write-backs in other income and tax provision reversal. Adjusted for these one-offs, PAT was Rs4.0bn for the quarter. ACEM in its press release highlighted that construction activity is expected to pick up pace after elections and also pointed to likely modest growth in cement demand.
· ASP higher than peers given North/West India mix benefit. We had highlighted strong operational performance from companies with exposure to North/West India given the upside in volume and realizations due to Binani’s plant shutdown. ACEM reported ASP growth of 5% q/q (vs. flat for peers but in-line with our estimates) aided by its exposure to North/West India markets. ACEM’s volume growth for the quarter was 2% y/y (vs. JPMe 3% and +9% for UTCEM).
· Lower-than-expected operating cost aide EBITDA: ACEM reported EBITDA of Rs5.9bn (+90% q/q; +6% y/y), which was slightly ahead of JPMe (Rs5.6bn), but much higher than Bloomberg consensus (Rs5.3bn). We estimate EBITDA/t at Rs969/t (+66% q/q; +4% y/y) and EBITDA margin expanded 820bp q/q to 22%. The EBITDA was aided by lower-than-expected operating cost/mt (-5% q/q vs. JPMe -3% q/q). While RM cost/Mt increased 5% q/q, other operating cost/mt declined 22% sequentially. Employee cost at Rs1.3bn was up 8% q/q (+7% y/y) after witnessing the 8% q/q decline in 4QCY13 (usually higher in 4Q).
· Tax reversal and write-back in other income drives PAT beat: Reported PAT at Rs5.2bn (+64% q/q, +7% y/y) was higher than expected due to Rs270mn write-back toward interest (on income tax related to previous years) and Rs948mn on tax provision reversal related to previous years. Adjusted for these one-offs, PAT came in at Rs4.0bn (+97% q/q, +15% y/y). Adjusted tax rate (for reversal of tax provision) was 27% vs. JPMe at 33% (adjusted for 1QCY13 was 34.8%).
· Valuations at all-time high: ACEM is currently trading at CY15E EV/MT $180/mt and 12.2x EV/EBITDA, which is almost at an all-time high for the company. Further, these multiples are on 2-yr forward EBITDA estimates that are ~45-50% higher than FY14/CY13 earnings and already building in demand recovery, and cement margin increase. At current valuations we see little value in the large-cap cement names (ACC, Ambuja, Ultratech) and expect some of the recent stock price momentum (+37% for ACEM, +33% for ACC, +27% for UTCEM and 11.5% for Sensex since end Jan) to reverse from current levels.
· Our earning estimates are under review following the results.
Table 1: ACEM Quarterly Earnings Summary
4QCY12
|
1QCY13
|
2QCY13
|
3QCY13
|
4QCY13
|
1QCY14
|
% q/q
|
% y/y
| |
Net sales
|
23,352
|
25,570
|
23,765
|
20,175
|
22,094
|
26,493
|
20%
|
4%
|
(Inc) Dec in stock
|
(193)
|
679
|
(625)
|
596
|
533
|
535
| ||
Raw Materials
|
1,625
|
1,832
|
1,655
|
1,434
|
1,676
|
2,025
|
21%
|
11%
|
Staff Costs
|
1,367
|
1,208
|
1,320
|
1,300
|
1,197
|
1,291
|
8%
|
7%
|
Power and fuel
|
5,473
|
5,495
|
5,560
|
4,568
|
5,007
|
5,783
|
16%
|
5%
|
Freight
|
5,816
|
6,408
|
6,142
|
5,247
|
5,745
|
6,660
|
16%
|
4%
|
Other Expenditure
|
4,764
|
4,417
|
4,485
|
4,351
|
4,845
|
4,329
|
-11%
|
-2%
|
Total Expenditure
|
18,851
|
20,038
|
18,537
|
17,496
|
19,002
|
20,622
|
9%
|
3%
|
EBITDA
|
4,501
|
5,533
|
5,228
|
2,679
|
3,092
|
5,872
|
90%
|
6%
|
Interest
|
243
|
132
|
171
|
178
|
169
|
161
|
-5%
|
22%
|
Depreciation
|
1,855
|
1,204
|
1,223
|
1,246
|
1,228
|
1,197
|
-2%
|
-1%
|
Other Income
|
881
|
1,494
|
744
|
815
|
861
|
1,319
|
53%
|
-12%
|
Profit before tax
|
3,284
|
5,690
|
4,578
|
2,070
|
2,556
|
5,832
|
128%
|
2%
|
Provn. for tax
|
1,174
|
1,982
|
1,336
|
891
|
393
|
1,579
|
302%
|
-20%
|
Recurring Profit
|
2,110
|
3,708
|
3,242
|
1,178
|
2,162
|
4,253
|
97%
|
15%
|
Exceptional
|
10
|
1,171
|
-
|
481
|
1,003
|
948
| ||
Reported Profit
|
2,120
|
4,879
|
3,242
|
1,660
|
3,165
|
5,200
|
64%
|
7%
|
EBITDA margin
|
19.3%
|
21.6%
|
22.0%
|
13.3%
|
14.0%
|
22.2%
| ||
Effective Tax Rate
|
35.7%
|
34.8%
|
29.2%
|
43.1%
|
15.4%
|
27.1%
| ||
Cement Sales MT
|
5.39
|
5.96
|
5.46
|
4.89
|
5.29
|
6.06
|
15%
|
2%
|
Realization per tonne
|
4,293
|
4,271
|
4,297
|
4,103
|
4,142
|
4,356
|
5%
|
2%
|
Operating cost/MT
|
3,498
|
3,363
|
3,396
|
3,581
|
3,591
|
3,403
|
-5%
|
1%
|
EBITDA/MT
|
835
|
928
|
958
|
548
|
584
|
969
|
66%
|
4%
|
Source: Company reports.
| Figure 1: Quarterly ASP/MT for Large Cement Cos | Figure 2: Quarterly Volume Growth for Large Cement Cos |
| Figure 3: Quarterly EBITDA Margin for Large Cement Cos | Figure 4: Quarterly EBITDA/MT for Large Cement Cos |
| Figure 5: Quarterly YoY ASP/MT Growth for Large Cement Cos | Figure 6: Quarterly YoY Operating Cost/MT Growth for Large Cement Cos |
| Figure 7: Quarterly Power Cost/MT for Large Cement Cos | Figure 8: Quarterly Freight/MT for Large Cement Cos |
| Figure 9: Quarterly YoY EBITDA Growth for Large Cement Cos | Figure 10: Quarterly YoY PAT Growth for Large Cement Cos |
Investment Thesis
The Indian cement industry continues to witness oversupply, with low demand trends and entry by new players leading to a volatile pricing environment. ACEM’s strong balance sheet, combined with its nationwide footprint, has helped ACEM retain its share in its key markets.
Post the Holcim transaction, ACEM becomes the quasi holding company (similar to GRASIM before the UTCEM-GRASIM transaction) in terms of its ACC stake, which usually warrants a holding company discount in India. Given that both entities would remain listed, the swap ratio is theoretical and hence ACEM in the near term would likely fall more than the implied swap ratio with ACC would suggest. Further, post the transaction, cash goes out from ACEM BS, which it would find difficult to access for its growth opportunities, except for dividend from ACC.
Valuation
We remain UW on ACEM with a Mar15 PT of Rs155, based on 8x CY15E EV/EBITDA, in-line with UTCEM’s target multiple.
Risks to Rating and Price Target
Key risks to our PT and estimates are a sharp recovery in cement demand to help drive higher-than-expected volume growth (and therefore utilization levels) and a reduction in operating cost per tonne improving margins.
CLICK links to Read MORE reports on:
Ambuja Cements,
JPMorgan
29 October 2013
Ambuja Cements:: Centrum
Steep fall in realization leads to OPM disappointment
We retain Sell rating on Ambuja with a revised price target of Rs149 (earlier:
Rs156) considering a) significant disappointment in current quarters’ results with
OPM at decade low levels b) downward revision of 9.4%/12% in CY13E/CY14E EPS
estimates, c) expensive valuations and d) expected dilution of 28% and cash outgo
of Rs35bn if restructuring deal proposed with ACC goes through. The result was a
significant disappointment with the company reporting EBITDA of Rs2.6bn (vs. est.
Rs3.5bn) and OPM at 12.7% (vs. est. 17.5%) primarily due to steep 6% QoQ fall in
realization contrary to ACC and UltraTech which posted realization drop of 1-2%
QoQ. EBITDA/tonne declined 52.4% YoY to Rs522 during the quarter and OPM was
at decade low levels. Though, earnings are expected to improve going forward, we
maintain Sell rating considering expensive valuations (12.6x CY14E EV/EBITDA).
We retain Sell rating on Ambuja with a revised price target of Rs149 (earlier:
Rs156) considering a) significant disappointment in current quarters’ results with
OPM at decade low levels b) downward revision of 9.4%/12% in CY13E/CY14E EPS
estimates, c) expensive valuations and d) expected dilution of 28% and cash outgo
of Rs35bn if restructuring deal proposed with ACC goes through. The result was a
significant disappointment with the company reporting EBITDA of Rs2.6bn (vs. est.
Rs3.5bn) and OPM at 12.7% (vs. est. 17.5%) primarily due to steep 6% QoQ fall in
realization contrary to ACC and UltraTech which posted realization drop of 1-2%
QoQ. EBITDA/tonne declined 52.4% YoY to Rs522 during the quarter and OPM was
at decade low levels. Though, earnings are expected to improve going forward, we
maintain Sell rating considering expensive valuations (12.6x CY14E EV/EBITDA).
CLICK links to Read MORE reports on:
Ambuja Cements,
centrum
12 August 2013
ACC benefits, Ambuja loses out, Holcim is the clear winner :Credit Suisse
● Holcim has announced restructuring of its ownership structure in
ACC and Ambuja, and in our view, Holcim, is the clear winner.
ACC minority shareholders benefit at the margin, while the
reorganisation is negative for Ambuja’s minority shareholders.
● Holcim pockets US$600 mn cash in the transaction which helps it
reduce leverage and maintain its investment grade rating. Holcim
also benefits from merger synergies (management forecast of
US$150 mn vs. CS's forecast of US$75 mn annually).
● Ambuja’s minorities are impacted by: (1) Holcim restricting use of
Ambuja’s existing cash to buy ACC; (2) committing future cash
flows to buy 10% of ACC over two years; and (3) the market may
apply a holding company discount to ACC’s stake which more
than offsets merger synergies.
● ACC minorities benefit from: (1) merger synergies; (2) a creeping
acquisition by Ambuja for a 10% stake in ACC could support ACC
prices; and (3) Holcim’s direct stake of 50% in ACC reduced to an
indirect stake of 30% . However, given high leverage at Holcim,
the overhang on existing cash of ACC will remain (US$600 mn
plus).
ACC and Ambuja, and in our view, Holcim, is the clear winner.
ACC minority shareholders benefit at the margin, while the
reorganisation is negative for Ambuja’s minority shareholders.
● Holcim pockets US$600 mn cash in the transaction which helps it
reduce leverage and maintain its investment grade rating. Holcim
also benefits from merger synergies (management forecast of
US$150 mn vs. CS's forecast of US$75 mn annually).
● Ambuja’s minorities are impacted by: (1) Holcim restricting use of
Ambuja’s existing cash to buy ACC; (2) committing future cash
flows to buy 10% of ACC over two years; and (3) the market may
apply a holding company discount to ACC’s stake which more
than offsets merger synergies.
● ACC minorities benefit from: (1) merger synergies; (2) a creeping
acquisition by Ambuja for a 10% stake in ACC could support ACC
prices; and (3) Holcim’s direct stake of 50% in ACC reduced to an
indirect stake of 30% . However, given high leverage at Holcim,
the overhang on existing cash of ACC will remain (US$600 mn
plus).
CLICK links to Read MORE reports on:
ACC,
Ambuja Cements,
Credit Suisse
Subscribe to:
Posts (Atom)